Gastrointestinal Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Mol Aspects Med. 2012 Feb;33(1):63-76. doi: 10.1016/j.mam.2011.11.001. Epub 2011 Nov 22.
The vitamin A (VA) metabolite all-trans retinoic acid (RA) plays a key role in mucosal immune responses. RA is produced by gut-associated dendritic cells (DC) and is required for generating gut-tropic lymphocytes and IgA-antibody-secreting cells (IgA-ASC). Moreover, RA modulates Foxp3(+) regulatory T cell (T(REG)) and Th17 effector T cell differentiation. Thus, although RA could be used as an effective "mucosal adjuvant" in vaccines, it also appears to be required for establishing intestinal immune tolerance. Here we discuss the roles proposed for RA in shaping intestinal immune responses and tolerance at the gut mucosal interface. We also focus on recent data exploring the mechanisms by which gut-associated DC acquire RA-producing capacity.
维生素 A(VA)代谢产物全反式视黄酸(RA)在黏膜免疫反应中发挥关键作用。RA 由肠道相关树突状细胞(DC)产生,是产生肠道趋向性淋巴细胞和 IgA 抗体分泌细胞(IgA-ASC)所必需的。此外,RA 还调节 Foxp3(+)调节性 T 细胞(T(REG))和 Th17 效应 T 细胞分化。因此,尽管 RA 可作为疫苗中的有效“黏膜佐剂”,但它似乎也是建立肠道免疫耐受所必需的。在这里,我们讨论了 RA 在塑造肠道黏膜界面处肠道免疫反应和耐受中的作用。我们还重点关注了最近的数据,这些数据探索了肠道相关 DC 获得产生 RA 能力的机制。